Ozempic Face When to See a Doctor: Causes, Treatment, and Warning Signs

Is Ozempic face a medical condition?

It is a description, not a diagnosis: the hollow-cheeked or loose-skinned look people notice after losing weight on semaglutide. Semaglutide is a GLP-1 receptor agonist that reduces calorie intake and body weight [4]. In STEP 1, 1,961 adults without diabetes lost a mean 14.9% of body weight on semaglutide 2.4 mg weekly versus 2.4% on placebo over 68 weeks [3]. That trial reported body weight, and 2.4 mg is the Wegovy dose.

Ozempic itself is approved for type 2 diabetes, cardiovascular risk reduction and kidney outcomes, not weight loss; Wegovy is the separate weight-management product [1][5].

When should you worry?

Swelling of the face, lips or tongue. The Ozempic label lists anaphylaxis and angioedema among serious hypersensitivity reactions. It says to discontinue the drug and promptly seek medical advice if a hypersensitivity reaction is suspected [1].

Sudden vision loss or rapidly worsening eyesight. In June 2025 the European Medicines Agency's safety committee concluded that NAION, a form of optic nerve damage, is a very rare side effect of semaglutide. It estimated up to 1 in 10,000 people, about one extra case per 10,000 person-years. It advised contacting a doctor without delay for sudden vision loss, and stopping semaglutide if NAION is confirmed [2]. The current US Ozempic label does not mention NAION [1].

A neck lump, trouble swallowing, shortness of breath or persistent hoarseness. The Ozempic boxed warning names these as symptoms of thyroid tumors. Semaglutide caused thyroid C-cell tumors in rodents; whether it does in humans is unknown [1].

What if the change is only cosmetic?

Facial hollowing or loose skin after weight loss is a cosmetic change. The signs above are different: facial or lip swelling, sudden vision loss or rapidly worsening eyesight, and thyroid-tumor symptoms such as a neck lump need prompt attention [1][2].